Main > INFLUENZA VIRUS > Infection. Vaccines. Additives > Recombinant NeurAminidase > Co.: USA. P (Dev./Patents)

---

Co.: USA. P (Dev./Patents)'s subsections
Company
Market. Expected by 2007
Patent
Status: Completed Phase II(b)
Web-Site

Co.: USA. P (Dev./Patents)'s products
This section has no products